# Efficacy of L-menthol on Breathlessness in Interstitial Lung Disease

> **NCT07398287** · PHASE2 · RECRUITING · sponsor: **Region Skane** · enrollment: 20 (estimated)

## Conditions studied

- Interstitial Lung Disease (ILD)

## Interventions

- **DRUG:** L-menthol
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT07398287
- **Lead sponsor:** Region Skane
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-04-13
- **Primary completion:** 2027-02
- **Final completion:** 2027-05
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2026-04-24

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07398287

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07398287, "Efficacy of L-menthol on Breathlessness in Interstitial Lung Disease". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT07398287. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*